Catalyst Wire Dossier Catalyst Wire Dossier

Investigational Parkinson's Disease Therapy (unnamed)

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Investigational Parkinson's Disease Therapy (unnamed), covering 2017-03-23 to 2017-03-23. Get the full timeline:

Most recent: Clinical Trial Update: Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa [Phase 3]

See pricing